Halozyme Therapeutics
HALO
#2362
Rank
$7.65 B
Marketcap
$64.63
Share price
4.02%
Change (1 day)
1.29%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): $0.46 Billion USD

According to Halozyme Therapeutics's latest financial reports the company's current earnings are $1.39 Billion USD. a decrease over its 2024 earnings that were of $0.55 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 $0.46 B-16.2%
2024 $0.55 B59.94%
2023 $0.34 B39.94%
2022 $0.24 B0.16%
2021 $0.24 B92.2%
2020 $0.12 B-278.96%
2019 -$72.26 Million-9.45%
2018 -$79.8 Million-229.51%
2017 $61.61 M-160.48%
2016 -$0.11 Billion216.03%
2015 -$32.24 Million-52.86%
2014 -$68.38 Million-18.09%
2013 -$83.48 Million55.88%
2012 -$53.56 Million169.94%
2011 -$19.84 Million-63.44%
2010 -$54.26 Million-7.19%
2009 -$58.46 Million15.91%
2008 -$50.44 Million83.89%
2007 -$27.43 Million78.1%
2006 -$15.41 Million16%
2005 -$13.28 Million45.24%
2004 -$9.15 Million682.42%
2003 -$1.17 Million1659.12%
2002 -$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$33.55 B 7,086.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$10.19 B 2,083.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$25.73 B 5,411.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$7.69 B 1,549.11%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-$0.51 Billion-208.17%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$30.78 M-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA